CDK5 inhibitor 20-223 structure
|
Common Name | CDK5 inhibitor 20-223 | ||
---|---|---|---|---|
CAS Number | 865317-30-2 | Molecular Weight | 305.381 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C19H19N3O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CDK5 inhibitor 20-223CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9; decreases pRB (S807/811) and pFAK (S732) levels in CRC cell lines, effectively blocks the kinase activity of CDK2 and CDK5 in multiple CRC cell lines; reduces migration of CRC cells, reduces cell growth in a panel of human CRC cell lines with mean IC50 of 362 nM; effectively slows tumor progression in mice models. |
Name | CDK5 inhibitor 20-223 |
---|
Description | CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9; decreases pRB (S807/811) and pFAK (S732) levels in CRC cell lines, effectively blocks the kinase activity of CDK2 and CDK5 in multiple CRC cell lines; reduces migration of CRC cells, reduces cell growth in a panel of human CRC cell lines with mean IC50 of 362 nM; effectively slows tumor progression in mice models. |
---|---|
References | References 1. Robb CM, et al. Oncotarget. 2017 Dec 28;9(4):5216-5232. View Related Products by Target Cyclin-dependent Kinase (CDK) |
Molecular Formula | C19H19N3O |
---|---|
Molecular Weight | 305.381 |